Japan Journal of Nursing Science
© Japan Academy of Nursing Science
Edited By: William L. Holzemer
Impact Factor: 0.458
ISI Journal Citation Reports © Ranking: 2015: 103/114 (Nursing (Social Science)); 106/116 (Nursing (Science))
Online ISSN: 1742-7924
AIMS AND SCOPE
The Japan Journal of Nursing Science is the official English language journal of the Japan Academy of Nursing Science. The purpose of the Journal is to provide a mechanism to share knowledge related to improving health care and promoting the development of nursing.
The Journal seeks original manuscripts reporting scholarly work on the art and science of nursing. Original Articles may be empirical and qualitative studies, Review Articles, Methodological Articles, Brief Reports, Case Studies and Letters to the Editor.
1. Original Article
Definition: Original research, consisting of Introduction, Methods, Results and Discussion. Original work must provide 10 references and an explanation about research findings.
Length: Should be approximately 5000 words (not counting the abstract, references, tables and/or figures).
2. Review Article
Definition: Critical evaluations of material about current research that has already been published by organizing, integrating and evaluating previously published material. Re-analyses as meta-analysis and systemic reviews are encouraged.
Length: Should not exceed 4000 words.
3. Methodological Article
Definition: New methodological approaches, modifications of existing methods, and discussions of quantitative and data analytic approaches and new qualitative methods/approaches.
Length: Should not exceed 4000 words.
Definition: Brief Reports, Case Studies, Comments, Letters to the Editor and Replies on previously published articles will be considered.
Length: Should not exceed 2000 words.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to the Journal’s readership. Except where otherwise stated, manuscripts are double-blind peer reviewed by two or more anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
At submission, authors are encouraged to indicate the names of potential reviewers as well as those whom they wish not to review the paper, but the editors will make the final choice.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of content, the Editor or the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
ENGLISH-LANGUAGE EDITING SERVICE
Authors are responsible for the linguistic accuracy of their manuscripts. All authors should seek advice from subject specialists with a sound knowledge of English. The cost will be bourn by the author, and a name of the copy editor, proofreader or editing service company should be mentioned during the submission steps. More information is available from http://www.wiley.co.jp/journals/editcontribute/editservlist.html.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/JJNS. Authors must supply an email address as all correspondence will be by email.
All articles submitted to the Journal must comply with the following instructions. Failure to do so will result in return or rejection of the manuscript.
• Submissions should be double-spaced throughout the manuscript, including tables. 35 to 40 lines per page is recommended.
• All margins should be at least 30 mm.
• Letter size must be 12 point and this also applies to letter size in tables.
• Do not use Enter at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β (Greek beta).
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 dpi) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
1. Launch your web browser (supported browsers include Internet Explorer 5.5 or higher, Firefox 1.0.4 or higher or Safari 1.2.4) and go to the Japan Journal of Nursing Science ScholarOne Manuscripts™ homepage (http://mc.manuscriptcentral.com/jjns).
2. Log-in or click the 'Create Account' option if you are a first-time user of ScholarOne Manuscripts™.
3. If you are creating a new account.
• After clicking on 'Create Account', enter your name and e-mail information and click 'Next'. Your e-mail information is very important.
• Enter your institution and address information as appropriate, and then click 'Next.'
• Enter a user ID and password of your choice (we recommend using your email address as your user ID), and then select your area of expertise. Click 'Finish'.
4. If you have an account but have forgotten your log in details, go to 'Password Help' on the ScholarOne Manuscripts™ homepage and enter your email address. The system will send you details on how to log in.
5. Log-in and select “Author Center.”
Submitting Your Manuscript
6. After you have logged in, click the 'Submit a New Manuscript' link in the menu bar.
7. Enter data and answer questions as appropriate.
8. Click the 'Save and Continue' button on each screen to save your work and advance to the next screen.
9. You are required to upload your files.
• Click on the 'Browse' button and locate the file on your computer.
• Select the designation of each file in the drop down next to the Browse button.
• When you have selected all files you wish to upload, click the 'Upload Files' button.
10. Review your submission (in both PDF and HTML formats) before sending to the Journal. Click the “Submit” button when you are finished reviewing.
(i) Material that might identify authorship of the paper should not be included in the manuscript file. The title page and specific acknowledgement have to be in a separate ‘title page’ file, which will not be for review.
(ii) The institutional review board of the university and hospital names which approved the study should not be included in the Methods section. Expression such as ‘This study was reviewed and approved by the research ethics committee of the author's institution’ should be used.
(iii) Include abstract at the beginning of the main manuscript file as well as entering it in the designated space.
(iv) Tables and figures should not be embedded in the manuscript. They should be prepared in separate files.
(v) When submitting a revised manuscript, a point-by-point response to reviewer’s comments is required in the Author’s Response section. In the manuscript, also highlight your changes by using bold or coloured text. The author’s name should not be included in the Author’s Response section for double-blind review.
(vi) Track changes function must not be used when a revised manuscript is submitted.
After submission, you will receive a confirmation email. You can also access ScholarOne Manuscripts™ any time to check the status of your manuscript. The Journal will inform you by email once a decision has been made.
CHANGES TO AUTHORSHIP
• Authors are expected to consider carefully the list and order of authors before submission.
• Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the Editor-in-Chief.
• Editor-in-Chief must receive the following from the corresponding author:
(a) the reason for the change in author list
(b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement.
Papers are accepted for publication in the journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the cover letter.
The cover letter must also contain an acknowledgement that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript.
Authors must declare any financial support or relationships that may pose a conflict of interest. It is the responsibility of the authors to disclose to the Editor any significant financial or personal interests they may have in products, technology or methodology mentioned in their manuscript. This information will be deemed confidential and will only be disclosed to manuscript reviewers if, in the opinion of the Editor, the information is directly pertinent for an informed review.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher) stating authorization to reproduce the material must be attached to the cover letter.
The cover letter of the paper should contain (i) the title; (ii) the full names of the authors; (iii) the addresses of the institutions at which the work was carried out; and (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied.
Authors must follow the ethical standards for human experimentation established in the Declaration of Helsinki in 1995 (as revised in Seoul 2008), available at http://www.wma.net/e/policy/b3.htm
The authors reporting studies involving human subjects must have obtained approval from appropriate institutional ethics board before any data collection to be reported in the study results was started. Upon request from the Journal editors, the author(s) must provide copies of the appropriate documentation. Local institutional approval must be indicated in the Methods section of the submitted manuscript.
If the study is exempt from institutional review board approval, or if your institution has no mechanism to approve protection of human subjects, a document of explanation signed by an appropriate institutional personnel must be submitted along with the manuscript and mentioned in the Methods section of the manuscript.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
In general, submission of a case report should be accompanied by the written consent of the subject (or parent/ guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it may not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
The Japan Journal of Nursing Science requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number at the end of their abstract. If you wish the editor to consider an unregistered trial, please explain briefly why the trial has not been registered. For author reference, examples of public clinical trial registries include: http://www.clinicaltrials.gov; http://clinicaltrials-dev.ifpma.org/; http://isrctn.org/; http://www.umin.ac.jp/ctr/index.htm.
CONFLICT OF INTEREST STATEMENT
Authors should declare any financial support or relationship that may pose conflict of interest as a Conflict of Interest Statement in the Disclosure section of your manuscript. The absence of any interest to disclose must be stated also. The Conflict of Interest Form is available from here (link). Download the form to your computer, open the form in Adobe Acrobat Reader, fill it out and then save it to your computer. Also please submit Author Statement Form from here (link). Submit the forms at Step 6 of the submission procedure as well as your manuscript.
COPYRIGHT, LICENSING and ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
FAQs about the terms and conditions of the standard copyright transfer agreements (CTA) in place for the journal, including terms regarding archiving of the accepted version of the paper, are available at: CTA Terms and Conditions FAQs
OnlineOpen — Wiley's Open Access Option
OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access, known as ‘gold road’ open access.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND).
For more information about the OnlineOpen license terms and conditions click here.
Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specially about Self-Archiving definitions and policies.
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Publication Manual of the American Psychological Association, 6th edition (2010), as shown at http://www.apastyle.org/index.aspx, and the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/.
The journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.
All measurements must be given in Système International (SI) units.
Abbreviations should be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter, use the abbreviation only.
Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DNA Data Bank of Japan (DDBJ), European Molecular Biology Laboratory (EMBL) or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.’ Addresses are as follows:
EMBL Nucleotide Sequence Submissions: www.ebi.ac.uk
PARTS OF THE MANUSCRIPT
Manuscripts should be presented in the following order: (i) title page; (ii) abstract and key words; (iii) text; (iv) acknowledgments; (v) disclosure statement; (vi) author contributions; (vii) references; (viii) appendices; (ix) figure legends; (x) tables (each table complete with title and footnotes); and (xi) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters including spaces) should be provided also.
Abstract and key words
All articles (except Comments, Replies and Letters to the Editor) must have a structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aim, Methods, Results, Conclusions. The abstract should not contain abbreviations or references.
Three to six key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list.
Authors should use the following subheadings to divide the sections of their manuscript: Abstract, Introduction, Methods, Results, Discussion and Conclusions.
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions also should be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
At the time of submission, each author must disclose and describe any involvement, financial or otherwise, that may potentially bias his or her work. Disclosure must be provided under the heading titled 'Disclosure' which should appear after the 'Acknowledgments' section and before the 'References' section. The absence of any interest to disclose also must be stated.
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section. JJNS adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). An ‘author’ is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should: (i) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (ii) have been involved in drafting the manuscript or revising it critically for important intellectual content; and (iii) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data or general supervision of the research group, alone, does not justify authorship. We suggest the following kind of format (please use initials to refer to each author's contribution): ‘A. B. and C. D. contributed to the conception and design of this study; E. F. performed the statistical analysis and drafted the manuscript; and G. H. critically reviewed the manuscript and supervised the whole study process. All authors read and approved the final manuscript.’ All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.
The author–date system of referencing as shown in the Publication Manual of the American Psychological Association is used (examples are given below). In the text, give the author’s name followed by the year in parentheses: Smith (2000). If there are two authors use ‘and’: Smith and Jones (2001); but if cited within parentheses use ‘&’: (Smith & Jones, 2001). When reference is made to a work by three to five authors, cite all authors the first time it occurs; subsequently, list the first author followed by et al. If there are six or more authors, cite only the first author and then use et al. For references to multiple sources, please list these in alphabetical order. In the reference list, references should be listed in alphabetical order.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first six followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. A. Smith, unpublished data, 2000). All citations mentioned in the text, tables or figures must be listed in the reference list.
A full publication title should be provided.
Authors are responsible for the accuracy of the references.
Vega K. J., Pina I., Krevsky B. (1996). Heart transplantation is associated with an increased risk for pancreatobiliary disease. Annals of Internal Medicine, 124, 980–983.
Online article not yet published in an issue
An online article that has not yet been published in an issue (therefore, has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.
Satoh, A., Kitamiya, C., Kudoh, H., Watanabe, M., Menzawa, K., Sasaki, H. (2009). Factors associated with late post-partum depression in Japan. Japan Journal of Nursing Science doi: : 10.1111/j.1742-7924.2009.00121.x
Ringsven M. K. & Bond D. (1996). Gerontology and leadership skills for nurses, 2nd ed. Albany, NY: Delmar Publishers.
Chapter in a book
Phillips S. J. & Whisnant J. P. (1995). Hypertension and stroke. In: J. H. Laragh & B. M. Brenner (Eds), Hypertension: pathophysiology, diagnosis, and management (2nd ed., pp. 465–478). New York: Raven Press.
Non-English journal article, title translated into English
Kondoh Y. (2001). Effects of flexed posture with boundaries following endotracheal suction in very low birth weight infants. Journal of Japan Academy of Nursing Science, 21(3), 11–20. (in Japanese)
Kisioğlu, A.N., Öztürk, M. Uskun E., Kırbıyık, S. (2002). Epidemiology and actions directed at preventive needlestick and sharp injuries in a university hospital's health care personnel, Türkiye Klinikleri Tıp Bilimleri, 22, 390-396. (in Turkish)
Ministry of Internal Affairs and Communications with the collaboration of Ministries and Agencies. (2012). Japan in figures and graphs. [Cited 27 Mar 2012.] Available from URL: http://www.e-stat.go.jp/SG1/estat/GL36010101. do?_toGL36010101_
References in Articles
We recommend the use of a tool such as Reference Manager and RefWorks for reference management and formatting.
Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate sheet with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, should be used (in that order) and *, ** and *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings and defined in the footnotes.
Type figure legends on a separate sheet. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
It is essential that the corresponding authors supply an email address to which correspondence can be emailed while their article is in production.
Word files of edited articles will be sent for checking via email, and should be returned to the Publisher within 3 days of receipt. It is essential that these files are checked carefully, as the cost of changes made at a later stage may be charged to the author. Full instructions on how to correct and return the file will be attached to the email.
Notification of the URL from where to download a Portable Document Format (PDF) typeset proof page, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off on by the Editor or held over to the next issue.
A minimum of 50 offprints will be provided upon request, at the author’s expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields.
If you have queries about offprints please email email@example.com
There are no publication fees associated with this Journal.
OVER PAGE CHARGE
Over page charge: For non-member authored articles, there is an over page charge of ¥10,000 per printed page for articles of 12 pages or more. The number of pages is determined at proof stage. Without payment, the article will not be published. Over page charge will be waived if the first author is a member of the Japan Academy of Nursing Science. Sample article is here. (For your reference: Preparing to fit 11 pages is about 5,000 words for main text, 2-3 tables or figures and 30 references)
The Japan Journal of Nursing Science is covered by Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a DOI, which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
WILEY JOURNALS ONLINE
Visit the Japan Journal of Nursing Science home page for more information, and Wiley’s web pages for submission guidelines and digital graphics standards. Japan Journal of Nursing Science is also available online via Wiley Online Library at http://wileyonlinelibrary.com/journal/jjns.
Last Updated: December 2015